Southwest Retina Research Center
Contributing to the Future of Medicine
Southwest Retina Research Center was established in 2018 to find new, better ways for patients to retain their vision, and help researchers better understand how to diagnose, treat and prevent these diseases. Our experienced investigators and knowledgeable staff are dedicated to providing our patients access to the best, innovative care. If you have a patient that is interested in volunteering for a clinical trial, whether purely observational, Phases I-IV of new gene therapies, implantable devices, or medicines, please consider the current clinical trials that are being conducted at our site.
Current Research Studies
Please see below the current studies being conducted at our site! If you have any questions about the following trials, and/or eligibility of a prospective patient, please don't hesitate to reach out to our research staff.
A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 gene therapy in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration
A Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants with nAMD
A Randomized, Partially Masked, Controlled, Phase 2b/3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants with nAMD
A Long-term Follow-Up Study to Evaluate the Safety and Efficacy of RGX-314 Following Subretinal Administration in Participants with Neovascular Age-related Macular Degeneration and Fellow Eye Treatment Substudy
A Three-Part, Phase I Study to Investigate the Safety, Tolerability, Pharmacokinetics, And Efficacy of Zifibancimig Following Intravitreal Administration of Multiple Ascending Doses and Continuous Delivery from The Port Delivery in Patients with Neovascular Age-Related Macular Degeneration
A decentralized epidemiological study of the progression of Age-related Macular Degeneration (AMD), and a prospective epidemiological study of the progression of primary open-angle glaucoma and glaucoma subtypes
A Phase IV, Multicenter, Open-Label, Single-Arm Study to Investigate Faricimab (Ro6867461) Treatment Response in Treatment-Naïve, Underrepresented Patients with Diabetic Macular Edema
A Multicenter, Prospective, Observational Study of the Progression of Intermediate Age-Related Macular Degeneration
A Randomized, Participant and Investigator Masked, Placebo-Controlled, Multicenter, Proof-Of-Concept Study to Assess the Safety and Efficacy of LNP023 (Iptacopan) In Patients with Early and Intermediate Age-Related Macular Degeneration
A Long-Term Follow-Up Study to Evaluate the Safety of GT005 In Participants with Geographic Atrophy Secondary to Age-Related Macular Degeneration Treated in A Gyroscope-Sponsored Antecedent Study
A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of The Port Delivery System With Ranibizumab In Patients With Neovascular Age-Related Macular Degeneration
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
If you are interested in referring a patient for research, please contact the Research Center at (970) 828-4164 or researchreferrals@sweyeconsultants.com.
Frequently Asked Questions
Clinical trials are the foundation of virtually all medical progress, and a vital step in research that helps experts better understand how best to treat patients with certain conditions or diseases. As such, clinical trials can be purely observational, or conducted in an effort to discover new drugs, surgical techniques, implantable devices and cutting-edge therapies. Participation in clinical trials is always completely voluntary, and patient care is of the utmost importance. Safety and ethics are a top priority, and all studies are conducted following strict guidelines which are closely overseen by an Institutional Review Board (IRB) and subject to audit by other safety regulatory agencies such as the United States Food and Drug Administration (FDA). To learn more about how clinical trials are run, especially at our site, visit our research center page.
Each clinical trial has eligibility criteria that must be met on who may participate, with criteria often based on factors such as age, gender, the type and stage of a disease or condition, previous treatment history, or other medical considerations. Participation is always voluntary and patients must be thoroughly informed of all study details, including possible benefits and safety concerns. If you are interested in learning more or becoming a research patient, please contact the Research Center at (970) 828-4164 or researchreferrals@sweyeconsultants.com, or speak with your Southwest Eye doctor at your next appointment. Please note that you do not need to be a current patient of Southwest Eye to participate!
As a clinical research participate, you may gain access to cutting-edge, investigational treatments, new medicines, and/or medical devices before they are widely available to the public. Many participants see volunteering as a way to take a more active role in their own health, and learn more about their condition. Clinical trials are conducted under strict protocols which involves close monitoring by our team of ophthalmologists and ophthalmic professionals, who are experts in our field. This meticulous observation provides valuable insights for the study, but also for the participants health status and ensure any changes are detected early and addressed.
Another draw that is more altruistic, is that volunteers are contributing actively to medical advancement, in conditions that don't just affect them. Without their participation, the development of new medicines, devices, and treatment guidelines would come to a standstill. Participating in clinical trials helps researchers prevent, treat or cure diseases to the benefit of future generations and patients with similar conditions, all over the world.
Participation in clinical trials is completely voluntary, and free. The patient burden for these appointments is taken into consideration and subsidized by the variety of organizations that sponsor clinical trials. Specifics are always completely transparent as part of the informed consent process and on each trials respective clinicaltrials.gov page. These sponsors can include physicians, medical institutions, pharmaceutical companies, and foundations.
For our regularly updated, complete list of active studies, please visit our current research page. Though we are conducting many trials, not all are currently enrolling new patients, so please don't hesitate to contact our team at (970) 828-4164 or researchreferrals@sweyeconsultants.com, or speak with your Southwest Eye doctor at your next appointment.
